BioSpace News Archive

Insulet Corporation today announced plans to release its financial results for the third quarter of 2018 on November 1, 2018

Kodiak Sciences Inc. today announced that it has launched an initial public offering of 9,000,000 shares of its common stock at an anticipated initial offering price between $13.00 and $15.00 per share

Live telerobotic procedure broadcast from Mayo Clinic to TCT Main Arena

Kyorin secures first commercial approval for vibegron

ALPN-101 preclinical data to be presented at the 2018 ACR/ARHP Annual Meeting and the 143rd Annual Meeting of the American Neurological Association

Goalkeepers Global Youth Poll reinforces role of youth in advancing the Global Goals

DermTech, Inc., the global leader in non-invasive molecular dermatology, announced today the publication of “Non-Invasive Gene Expression Testing to Rule Out Melanoma,” by Dr. Jason Rivers of the Department of Dermatology and Skin Science, University of British Columbia, Vancouver, BC, Canada, and colleagues in Skin Therapy Letter.

BIO Ventures for Global Health (BVGH) was featured at last week’s Biden Cancer Summit, hosted by Vice President Joe Biden and Dr. Jill Biden, for its commitment to addressing Africa’s long under-recognized cancer epidemic through its African Access Initiative (AAI).

On September 20, 2018, ThermoLife International, LLC filed suit in Arizona Federal District Court against Neogenis Labs, LLC d/b/a HumanN (“HumanN”). ThermoLife is a leading ingredient and technology supplier in the dietary supplement industry.

Company will host a business update conference call on September 25, 2018 at 4:30 PM Eastern Time